Yuzhpharm to launch production of generics for 200 million rubles

The facilities of the Yuzhpharm company are located in the village of Troitskaya in the Krymsky district. In 2023, the company received a subsidy to compensate for expenses related to the production of import-substituting products in the region.

According to SPARK-Interfax, Yuzhpharm LLC was registered in the village of Ivanovskaya, Krasnodar Krai, in 2007. The company's beneficiary is Mikhail Kravchuk. The legal entity's revenue for the past two years is not reflected in the system. In 2022, Yuzhpharm earned 1.7 billion rubles.

According to the State Register of Medicines, Yuzhpharm is both the holder of a number of its own registration certificates and a contract manufacturing site for several pharmaceutical companies. Among them are Alvils , Moskhimfarmpreparaty named after N.A. Semashko, Vita Line and others.

In December 2020, the Russian Ministry of Industry and Trade issued a license to Yuzhpharm LLC to produce a medicine from the VED list – azathioprine, the shortage of which was then complained about by patient organizations. “In the near future, the company will begin producing this drug to cover the needs of the Russian Federation. Previously, the price for azathioprine was re-registered, which will ensure its availability to the general population,” the Ministry of Industry and Trade noted.